Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.
Study Details
Study Description
Brief Summary
To evaluate the confocal microscopy findings at the corneal epithelium and anterior stroma after epi-LASIK Surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
10 eyes of 10 patients underwent epi-LASK, epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes. A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) before and at 2 weeks and 1 month after surgery. Corneal epithelial thickness and the Anterior stroma morphology were analyzed by using the NAVIS software V. 3.5.0 (NIDEK, Multi-Instrument Diagnostic System, Japan).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: A Epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes |
Procedure: Epi-LASK
10 eyes of 10 patients underwent epi-LASK, epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes
|
Outcome Measures
Primary Outcome Measures
- A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) [Before and at 2 weeks and 1 month after surgery]
Secondary Outcome Measures
- There are no secondary outcome measures specified for this study [There are no secondary outcome measures specified for this study]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients asking for epi-LASIK surgery
-
Patients with stable refraction in the last year
-
Patients without systemic and ocular disease
-
Patients with 500 microns in pachymetry
-
Normal topography
Exclusion Criteria:
-
Patients cannot attend their appointments
-
Residual, recurrent or active ocular disease
-
Previous ocular surgery except LASIK
-
Autoimmune or connective tissue disease
-
Pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Asociación Para Evitar la Ceguera en Mëxico, Hospital "Luis Sánchez Bulnes". | Mexico city | Distrito Federal | Mexico | 04030 |
Sponsors and Collaborators
- Asociación para Evitar la Ceguera en México
Investigators
- Principal Investigator: Ramirez F Manuel, MD, Asociación para Evitar la Ceguera en México
Study Documents (Full-Text)
None provided.More Information
Publications
- Gamaly TO, El Danasoury A, El Maghraby A. A prospective, randomized, contralateral eye comparison of epithelial laser in situ keratomileusis and photorefractive keratectomy in eyes prone to haze. J Refract Surg. 2007 Nov;23(9 Suppl):S1015-20.
- Hoang-Xuan T, Arnaud D, Souissi K, Cornu S. [Epi-LASIK, a novel surface photoablation technique]. J Fr Ophtalmol. 2007 May;30(5):535-8. French.
- Katsanevaki VJ, Kalyvianaki MI, Kavroulaki DS, Pallikaris IG. One-year clinical results after epi-LASIK for myopia. Ophthalmology. 2007 Jun;114(6):1111-7. Epub 2007 Feb 23.
- Kollias A, Ulbig MW, Spitzlberger GM, Abdallat WH, Froehlich S, Welge-Luessen U, Lackerbauer CA. Epi-LASIK using the Amadeus II microkeratome: evaluation of cut quality using light and electron microscopy. J Cataract Refract Surg. 2007 Dec;33(12):2118-21.
- Cornea 3